Cutler Group’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Cutler Group’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,500	Closed	-$25K	–	7649
2015 Q4	$25K	Buy	+1,500	New	+$26.9K	﹤0.01%	3201

Other funds holding SCMP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Redwood Investments Boston, Massachusetts $267M AUM 11.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cutler Group's SCMP Position: Q1 2016 in Review

Cutler Group sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2016, closing a stake of 1,500 shares — an estimated $25K sold.

Cutler Group first reported a position in SCMP in Q4 2015 and held it in 1 quarter. The position peaked at $25K in Q4 2015. 134 funds tracked by Wall St. Rank hold SCMP as of Q1 2016.

Cutler Group reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
Cutler Group sold 1,500 Sucampo Pharmaceuticals, Inc. shares in Q1 2016, an estimated $25K.
Cutler Group first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2015 and held it in 1 quarter.
Cutler Group's Sucampo Pharmaceuticals, Inc. position peaked at $25K in Q4 2015.
134 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2016.

Based on Cutler Group's 13F filing for Q1 2016, filed 8 Jun 2016.